24374-77-4 Usage
Uses
Used in Cancer Treatment:
1-(1H-benzimidazol-2-yl)-3-butylurea is used as an inhibitor for protein tyrosine phosphatases in the pharmaceutical industry. Its application is aimed at preventing tumor growth by targeting and inhibiting the activity of these enzymes, which are often dysregulated in cancer cells, contributing to uncontrolled cell proliferation and tumor progression.
Used in Autoimmune Disease Treatment:
In the medical field, 1-(1H-benzimidazol-2-yl)-3-butylurea is also being explored as a potential therapeutic agent for autoimmune diseases. Its ability to modulate the activity of protein tyrosine phosphatases may help in regulating the immune system and reducing the severity of autoimmune conditions.
Used in Diabetes Treatment:
1-(1H-benzimidazol-2-yl)-3-butylurea is being investigated for its potential use in treating diabetes. 1-(1H-benzimidazol-2-yl)-3-butylurea's impact on protein tyrosine phosphatases, which are involved in insulin signaling pathways, may offer a new approach to managing blood sugar levels and improving the treatment of diabetes.
Overall, 1-(1H-benzimidazol-2-yl)-3-butylurea is a promising compound with various applications in the medical and pharmaceutical industries, primarily due to its ability to inhibit protein tyrosine phosphatases, which are implicated in cancer, autoimmune diseases, and diabetes.
Check Digit Verification of cas no
The CAS Registry Mumber 24374-77-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,3,7 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 24374-77:
(7*2)+(6*4)+(5*3)+(4*7)+(3*4)+(2*7)+(1*7)=114
114 % 10 = 4
So 24374-77-4 is a valid CAS Registry Number.
24374-77-4Relevant articles and documents
Preparation of 2,4-dioxo-1,2,3,4-tetrahydro-s-triazino-[1,2-a]-benzimidazoles
-
, (2008/06/13)
2,4-Dioxo-1,2,3,4-tetrahydro-s-triazino-[1,2-a]-benzimidazoles of the formula STR1 are produced by reacting a benzimidazole compound of the formula STR2 with a diphenyl carbonate of the formula STR3 wherein R1 is optionally substituted alkyl or aryl, alkenyl or dialkylamino, R2 is hydrogen, alkyl or trifluoromethyl, R3 is any of the R1 radicals or hydroxycarbonylalkyl, and R4 is hydrogen, alkyl or halogen. The reaction can be effected employing the benzimidazole in impure form, without isolation, in the vessel in which it is formed. Those compounds wherein R1 is a variously ω-substituted alkyl radical and R2 is hydrogen or methyl are new and all the compounds exhibit fungicidal activity.
